Circulating Tumor DNA in Cervical Cancer: Clinical Utility and Medico-Legal Perspectives

Area of Science:

• Oncology
• Molecular Diagnostics
• Medical Law

Background:

• Cervical cancer, linked to human papillomavirus (HPV), is a major global cause of cancer mortality in women.
• Circulating tumor DNA (ctDNA), released by cancer cells, can be found in bodily fluids.
• ctDNA detection offers potential for non-invasive cancer monitoring.

Purpose of the Study:

• To review current knowledge on circulating tumor HPV DNA (ctHPV DNA) in cervical cancer.
• To explore the clinical utility of ctHPV DNA for prognosis and recurrence assessment.
• To examine the medico-legal implications of ctHPV DNA detection in cervical cancer management.

Main Methods:

• Systematic PubMed search for "ctHPV" or "circulating tumor DNA" and "cervical cancer" (last 10 years).
• Hand-searching for literature on medico-legal aspects.
• Evaluation of study relevance and methodological quality.
• Review of detection techniques including PCR, ddPCR, and NGS.

Main Results:

• ctHPV DNA detection is a promising tool for assessing cervical cancer prognosis and disease recurrence.
• Various detection methods like PCR, ddPCR, and NGS are available.
• The review highlights the need to address clinical and medico-legal challenges.

Conclusions:

• ctHPV DNA holds significant potential for improving cervical cancer management.
• Clinical application requires careful consideration of diagnostic accuracy and interpretation.
• Medico-legal aspects, including errors, liability, and data protection, are critical for implementation.